THE POSSIBLE RELATIONSHIP BETWEEN THE MATERNAL ADMINISTRATION OF SULPHAMETHOXYPYRIDAZINE AND HYPERBILIRUBINAEMIA IN THE NEWBORN.
D005260:Female; D006801:Humans; D006932:Hyperbilirubinemia; D007223:Infant; D007231:Infant, Newborn; D007565:Jaundice; D007567:Jaundice, Neonatal; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011248:Pregnancy Complications; D013421:Sulfamethoxypyridazine; D014116:Toxicology
D013421:Sulfamethoxypyridazine
HYPERBILIRUBINEMIA; INFANT, NEWBORN; JAUNDICE, NEONATAL; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; SULFAMETHOXYPYRIDAZINE; TOXICOLOGIC REPORT